C4 Therapeutics, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CCCC Company Description
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
CCCC Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CCCC Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CCCC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CCCC's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CCCC in WallStreetBets Daily Discussion
CCCC News
Recent insights relating to CCCC
CNBC Recommendations
Recent picks made for CCCC stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CCCC
Corporate Flights
Flights by private jets registered to CCCC
Our Analysis